Cancer Diagnostics Market 2014 - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2020

on Monday, 17 November 2014 include new market research report " Global Cancer Diagnostics (Tests, Imaging, Endoscopy and Biopsy) Market: Industry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.

This report on cancer diagnostics analyzes the current as well as future prospects of various facets of the market in detail. It provides an in-depth and comprehensive analysis of the cancer diagnostics market. The report includes an elaborate executive summary, which covers a market snapshot representing key findings from the study for various segments such as diagnostic methods, applications, and geography (North America, Europe, Asia-Pacific and Rest of the World).

For the research on this topic, we conducted in-depth interviews and discussions with a wide range of key opinion leaders within cancer diagnostics market, which was supplemented by extensive secondary research. The report provides market size in terms of USD million for each segment for the period 2012 to 2020, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall cancer diagnostics market and the segments has also been provided in the report for the forecast period 2014 to 2020, considering 2012 and 2013 as the base years. Growth rates for each segment within the cancer diagnostics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

The global cancer diagnostics market is categorized based on the diagnostic methods into four major segments, namely, tumor biomarker tests, imaging, endoscopy, and biopsy. The market analysis provided for tumor biomarker tests include revenue from major cancer biomarker tests such as prostate specific antigen (PSA) tests, human epidermal growth factor receptor 2 (HER2) tests, circulating tumor cells (CTC) tests , carcinoembryonic antigen (CEA) test, anaplastic lymphoma kinase (ALK) test, BRCA gene tests, and other tests such as AFP, CA 19-9, CA 125 tests. The report also provides market size for imaging procedures for cancer diagnostics, namely, magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), x-ray and ultrasound imaging. The market size estimation for endoscopies such as colonoscopy, sigmoidoscopy, bronchoscpopy and colposcopy; and biopsies such as bone marrow biopsy, needle biopsy and endoscopic biopsy are provided in the report.

Browse More related reports to Medical Equipments at:

The study is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interaction via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases for patents, clinical trials, demographics, disease incidence/prevalence, etc.

About Us:

ResearchMoz ( ) is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.

For More Information Kindly Contact: 
Mrs.Sheela AK
Toll Free: 866-997-4948


Post a Comment